Transcript : TELA Bio, Inc., Q1 2026 Earnings Call, May 12, 2026
TELA Bio Inc TELA
$0.91
โผ -8.59%
($-0.09)
Open
$0.96
Prev Close
$0.99
Day Range
$0.86 โ $0.99
52W Range
$0.50 โ $2.20
Market Cap
$40.51M
Beta
1.28
EPS (TTM)
$-0.83
๐ Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-11-08 |
| Shares Out. | 44,740,000 |
| Website | telabio.com/ โ |
| Phone | 13026587581 |
TELA Bio Inc is a publicly traded company under the ticker symbol TELA on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
11 analysts (2026-05-01)
๐ฐ Latest News for TELA
TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance
TELA Bio Q1 2026 Earnings Call Transcript
12 Health Care Stocks Moving In Tuesday's After-Market Session
TELA Bio FY2026 Revenue expected to be more than $86.697M vs $86.849M Est
TELA Bio Sees Q2 Sales $20.000M vs $21.043M Est
TELA Bio Q1 EPS $(0.21) Misses $(0.18) Estimate, Sales $19.059M Beat $18.597M Estimate
